Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 281

1.

Brain metabolic signatures across the Alzheimer's disease spectrum.

Sala A, Caprioglio C, Santangelo R, Vanoli EG, Iannaccone S, Magnani G, Perani D.

Eur J Nucl Med Mol Imaging. 2019 Dec 7. doi: 10.1007/s00259-019-04559-2. [Epub ahead of print]

PMID:
31811345
2.

The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy.

Dodich A, Cerami C, Inguscio E, Iannaccone S, Magnani G, Marcone A, Guglielmo P, Vanoli G, Cappa SF, Perani D.

Neuroimage Clin. 2019 Oct 21;24:102009. doi: 10.1016/j.nicl.2019.102009. [Epub ahead of print]

3.

Italian consensus recommendations for the biomarker-based etiological diagnosis in MCI patients.

Boccardi M, Nicolosi V, Festari C, Bianchetti A, Cappa S, Chiasserini D, Falini A, Guerra UP, Nobili F, Padovani A, Sancesario GM, Morbelli S, Parnetti L, Tiraboschi P, Muscio C, Perani D, Pizzini FB, Beltramello A, Salvini Porro G, Ciaccio M, Schillaci O, Trabucchi M, Tagliavini F, Frisoni GB.

Eur J Neurol. 2019 Nov 6. doi: 10.1111/ene.14117. [Epub ahead of print]

PMID:
31692118
4.

TAM Receptor Pathways at the Crossroads of Neuroinflammation and Neurodegeneration.

Tondo G, Perani D, Comi C.

Dis Markers. 2019 Sep 15;2019:2387614. doi: 10.1155/2019/2387614. eCollection 2019. Review.

5.

High body mass index, brain metabolism and connectivity: an unfavorable effect in elderly females.

Sala A, Malpetti M, Ferrulli A, Gianolli L, Luzi L, Perani D; Alzheimer’s Disease Neuroimaging Initiative (ADNI) database.

Aging (Albany NY). 2019 Oct 9;11(19):8573-8586. doi: 10.18632/aging.102347. Epub 2019 Oct 9.

6.

The Italian INTERCEPTOR Project: From the Early Identification of Patients Eligible for Prescription of Antidementia Drugs to a Nationwide Organizational Model for Early Alzheimer's Disease Diagnosis.

Rossini PM, Cappa SF, Lattanzio F, Perani D, Spadin P, Tagliavini F, Vanacore N.

J Alzheimers Dis. 2019;72(2):373-388. doi: 10.3233/JAD-190670.

PMID:
31594234
7.

Variant-specific vulnerability in metabolic connectivity and resting-state networks in behavioural variant of frontotemporal dementia.

Malpetti M, Carli G, Sala A, Cerami C, Marcone A, Iannaccone S, Magnani G, Perani D.

Cortex. 2019 Nov;120:483-497. doi: 10.1016/j.cortex.2019.07.018. Epub 2019 Aug 10.

PMID:
31493687
8.

Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.

Beretta L, Caminiti SP, Santangelo R, Magnani G, Ferrari-Pellegrini F, Caffarra P, Perani D.

Neuropsychologia. 2019 Oct;133:107174. doi: 10.1016/j.neuropsychologia.2019.107174. Epub 2019 Aug 22.

PMID:
31446008
9.

The CSF p-tau181/Aβ42 Ratio Offers a Good Accuracy "In Vivo" in the Differential Diagnosis of Alzheimer's Dementia.

Santangelo R, Dell'Edera A, Sala A, Cecchetti G, Masserini F, Caso F, Pinto P, Leocani L, Falautano M, Passerini G, Martinelli V, Comi G, Perani D, Magnani G.

Curr Alzheimer Res. 2019;16(7):587-595. doi: 10.2174/1567205016666190725150836.

PMID:
31345148
10.

Vulnerability of multiple large-scale brain networks in dementia with Lewy bodies.

Sala A, Caminiti SP, Iaccarino L, Beretta L, Iannaccone S, Magnani G, Padovani A, Ferini-Strambi L, Perani D.

Hum Brain Mapp. 2019 Oct 15;40(15):4537-4550. doi: 10.1002/hbm.24719. Epub 2019 Jul 19.

PMID:
31322307
11.

Factors affecting the harmonization of disease-related metabolic brain pattern expression quantification in [18F]FDG-PET (PETMETPAT).

Kogan RV, de Jong BA, Renken RJ, Meles SK, van Snick PJH, Golla S, Rijnsdorp S, Perani D, Leenders KL, Boellaard R; JPND-PETMETPAT Working Group.

Alzheimers Dement (Amst). 2019 Jun 22;11:472-482. doi: 10.1016/j.dadm.2019.04.002. eCollection 2019 Dec.

12.

Brain Molecular Connectivity in Neurodegenerative Diseases: Recent Advances and New Perspectives Using Positron Emission Tomography.

Sala A, Perani D.

Front Neurosci. 2019 Jun 14;13:617. doi: 10.3389/fnins.2019.00617. eCollection 2019. Review.

13.

A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies.

Perani D, Iaccarino L, Lammertsma AA, Windhorst AD, Edison P, Boellaard R, Hansson O, Nordberg A, Jacobs AH; IMBI Project.

Alzheimers Dement. 2019 Aug;15(8):1081-1103. doi: 10.1016/j.jalz.2019.02.004. Epub 2019 Jun 21.

PMID:
31230910
14.

Predicting long-term clinical stability in amyloid-positive subjects by FDG-PET.

Iaccarino L, Sala A, Perani D; Alzheimer's Disease Neuroimaging Initiative.

Ann Clin Transl Neurol. 2019 May 24;6(6):1113-1120. doi: 10.1002/acn3.782. eCollection 2019 Jun.

15.

Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.

Pilotto A, Schiano di Cola F, Premi E, Grasso R, Turrone R, Gipponi S, Scalvini A, Cottini E, Paghera B, Garibotto V, Rizzetti MC, Bonanni L, Borroni B, Morbelli S, Nobili F, Guerra UP, Perani D, Padovani A.

Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1642-1651. doi: 10.1007/s00259-019-04324-5. Epub 2019 May 16.

PMID:
31098748
16.

Cross-Modal Audiovisual Modulation of Corticospinal Motor Synergies in Professional Piano Players: A TMS Study during Motor Imagery.

Rossi S, Spada D, Emanuele M, Ulivelli M, Santarnecchi E, Fadiga L, Prattichizzo D, Rossi A, Perani D.

Neural Plast. 2019 Apr 4;2019:1328453. doi: 10.1155/2019/1328453. eCollection 2019.

17.

Application of advanced brain positron emission tomography-based molecular imaging for a biological framework in neurodegenerative proteinopathies.

Perani D, Iaccarino L, Jacobs AH; IMBI Brain Imaging Working Group.

Alzheimers Dement (Amst). 2019 Apr 16;11:327-332. doi: 10.1016/j.dadm.2019.02.004. eCollection 2019 Dec.

18.

Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria.

Caminiti SP, Sala A, Iaccarino L, Beretta L, Pilotto A, Gianolli L, Iannaccone S, Magnani G, Padovani A, Ferini-Strambi L, Perani D.

Alzheimers Res Ther. 2019 Feb 23;11(1):20. doi: 10.1186/s13195-019-0473-4.

19.

Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis.

Sala A, Iaccarino L, Fania P, Vanoli EG, Fallanca F, Pagnini C, Cerami C, Calvo A, Canosa A, Pagani M, Chiò A, Cistaro A, Perani D.

Eur J Nucl Med Mol Imaging. 2019 May;46(5):1117-1131. doi: 10.1007/s00259-018-4246-2. Epub 2019 Jan 7.

PMID:
30617963
20.

Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation.

Castelnovo V, Caminiti SP, Riva N, Magnani G, Silani V, Perani D.

Neurol Sci. 2019 Mar;40(3):515-521. doi: 10.1007/s10072-018-3685-7. Epub 2018 Dec 15.

PMID:
30554355
21.

Prefrontal Cortical Stimulation in Tourette Disorder: Proof-of-concept Clinical and Neuroimaging Study.

Perani D, Lalli S, Iaccarino L, Alongi P, Gambini O, Franzini A, Albanese A.

Mov Disord Clin Pract. 2018 Oct 3;5(5):499-505. doi: 10.1002/mdc3.12648. eCollection 2018 Sep-Oct.

22.

EEG Hyperconnectivity Study on Saxophone Quartet Playing in Ensemble.

Greco A, Spada D, Rossi S, Perani D, Valenza G, Scilingo EP.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:1015-1018. doi: 10.1109/EMBC.2018.8512409.

PMID:
30440563
23.

Unfavourable gender effect of high body mass index on brain metabolism and connectivity.

Malpetti M, Sala A, Vanoli EG, Gianolli L, Luzi L, Perani D.

Sci Rep. 2018 Aug 22;8(1):12584. doi: 10.1038/s41598-018-30883-y.

24.

The brain metabolic signature of visual hallucinations in dementia with Lewy bodies.

Iaccarino L, Sala A, Caminiti SP, Santangelo R, Iannaccone S, Magnani G, Perani D.

Cortex. 2018 Nov;108:13-24. doi: 10.1016/j.cortex.2018.06.014. Epub 2018 Jul 4.

PMID:
30098477
25.

Low-dose CT for the spatial normalization of PET images: A validation procedure for amyloid-PET semi-quantification.

Presotto L, Iaccarino L, Sala A, Vanoli EG, Muscio C, Nigri A, Bruzzone MG, Tagliavini F, Gianolli L, Perani D, Bettinardi V.

Neuroimage Clin. 2018 Jul 19;20:153-160. doi: 10.1016/j.nicl.2018.07.013. eCollection 2018.

26.

PET Evaluation of Late Cerebral Effect in Advanced Radiation Therapy Techniques for Cranial Base Tumors.

Alongi P, Iaccarino L, Losa M, Del Vecchio A, Gerevini S, Plebani V, Di Muzio N, Mortini P, Gianolli L, Perani D.

Curr Radiopharm. 2018;11(2):86-91. doi: 10.2174/1874471011666180525134301.

PMID:
29804540
27.

Cognitive training with action-related verbs induces neural plasticity in the action representation system as assessed by gray matter brain morphometry.

Ghio M, Locatelli M, Tettamanti A, Perani D, Gatti R, Tettamanti M.

Neuropsychologia. 2018 Jun;114:186-194. doi: 10.1016/j.neuropsychologia.2018.04.036. Epub 2018 Apr 30.

PMID:
29723600
28.

A biomarker study in long-lasting amnestic mild cognitive impairment.

Cerami C, Dodich A, Iannaccone S, Magnani G, Santangelo R, Presotto L, Marcone A, Gianolli L, Cappa SF, Perani D.

Alzheimers Res Ther. 2018 Apr 25;10(1):42. doi: 10.1186/s13195-018-0369-8.

29.

Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease.

Pilotto A, Premi E, Paola Caminiti S, Presotto L, Turrone R, Alberici A, Paghera B, Borroni B, Padovani A, Perani D.

Neurology. 2018 Mar 20;90(12):e1029-e1037. doi: 10.1212/WNL.0000000000005161. Epub 2018 Feb 16.

PMID:
29453242
30.

FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.

Caminiti SP, Ballarini T, Sala A, Cerami C, Presotto L, Santangelo R, Fallanca F, Vanoli EG, Gianolli L, Iannaccone S, Magnani G, Perani D; BIOMARKAPD Project.

Neuroimage Clin. 2018 Jan 28;18:167-177. doi: 10.1016/j.nicl.2018.01.019. eCollection 2018.

31.

An in vivo 11C-PK PET study of microglia activation in Fatal Familial Insomnia.

Iaccarino L, Presotto L, Bettinardi V, Gianolli L, Roiter I, Capellari S, Parchi P, Cortelli P, Perani D.

Ann Clin Transl Neurol. 2017 Dec 9;5(1):11-18. doi: 10.1002/acn3.498. eCollection 2018 Jan.

32.

Bilingualism and healthy aging: Aging effects and neural maintenance.

Borsa VM, Perani D, Della Rosa PA, Videsott G, Guidi L, Weekes BS, Franceschini R, Abutalebi J.

Neuropsychologia. 2018 Mar;111:51-61. doi: 10.1016/j.neuropsychologia.2018.01.012. Epub 2018 Feb 4.

PMID:
29360516
33.

Social and cognitive control skills in long-life occupation activities modulate the brain reserve in the behavioural variant of frontotemporal dementia.

Dodich A, Carli G, Cerami C, Iannaccone S, Magnani G, Perani D.

Cortex. 2018 Feb;99:311-318. doi: 10.1016/j.cortex.2017.12.006. Epub 2017 Dec 19.

PMID:
29328983
34.

Affective and cooperative social interactions modulate effective connectivity within and between the mirror and mentalizing systems.

Arioli M, Perani D, Cappa S, Proverbio AM, Zani A, Falini A, Canessa N.

Hum Brain Mapp. 2018 Mar;39(3):1412-1427. doi: 10.1002/hbm.23930. Epub 2017 Dec 19.

PMID:
29265483
35.

The emerging role of PET imaging in dementia.

Iaccarino L, Sala A, Caminiti SP, Perani D.

F1000Res. 2017 Oct 12;6:1830. doi: 10.12688/f1000research.11603.1. eCollection 2017. Review.

36.

Unaware Processing of Tools in the Neural System for Object-Directed Action Representation.

Tettamanti M, Conca F, Falini A, Perani D.

J Neurosci. 2017 Nov 1;37(44):10712-10724. doi: 10.1523/JNEUROSCI.1061-17.2017. Epub 2017 Oct 4.

37.

Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38.

Manes M, Alberici A, Di Gregorio E, Boccone L, Premi E, Mitro N, Pasolini MP, Pani C, Paghera B, Perani D, Orsi L, Costanzi C, Ferrero M, Zoppo A, Tempia F, Caruso D, Grassi M, Padovani A, Brusco A, Borroni B.

Ann Neurol. 2017 Oct;82(4):615-621. doi: 10.1002/ana.25059. Epub 2017 Oct 22.

38.

A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.

Iaccarino L, Chiotis K, Alongi P, Almkvist O, Wall A, Cerami C, Bettinardi V, Gianolli L, Nordberg A, Perani D.

J Alzheimers Dis. 2017;59(2):603-614. doi: 10.3233/JAD-170158.

PMID:
28671117
39.

Altered brain metabolic connectivity at multiscale level in early Parkinson's disease.

Sala A, Caminiti SP, Presotto L, Premi E, Pilotto A, Turrone R, Cosseddu M, Alberici A, Paghera B, Borroni B, Padovani A, Perani D.

Sci Rep. 2017 Jun 26;7(1):4256. doi: 10.1038/s41598-017-04102-z.

40.

Gender differences in healthy aging and Alzheimer's Dementia: A 18 F-FDG-PET study of brain and cognitive reserve.

Malpetti M, Ballarini T, Presotto L, Garibotto V, Tettamanti M, Perani D; Alzheimer's Disease Neuroimaging Initiative (ADNI) database;; Network for Efficiency and Standardization of Dementia Diagnosis (NEST-DD) database.

Hum Brain Mapp. 2017 Aug;38(8):4212-4227. doi: 10.1002/hbm.23659. Epub 2017 May 31.

PMID:
28561534
41.

Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging.

Cerami C, Iaccarino L, Perani D.

Int J Mol Sci. 2017 May 5;18(5). pii: E993. doi: 10.3390/ijms18050993. Review.

42.

An In Vivo 11C-(R)-PK11195 PET and In Vitro Pathology Study of Microglia Activation in Creutzfeldt-Jakob Disease.

Iaccarino L, Moresco RM, Presotto L, Bugiani O, Iannaccone S, Giaccone G, Tagliavini F, Perani D.

Mol Neurobiol. 2018 Apr;55(4):2856-2868. doi: 10.1007/s12035-017-0522-6. Epub 2017 Apr 28.

PMID:
28455699
43.

Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease.

Caminiti SP, Presotto L, Baroncini D, Garibotto V, Moresco RM, Gianolli L, Volonté MA, Antonini A, Perani D.

Neuroimage Clin. 2017 Mar 27;14:734-740. doi: 10.1016/j.nicl.2017.03.011. eCollection 2017.

44.

Biomarkers for the diagnosis of Alzheimer's disease in clinical practice: an Italian intersocietal roadmap.

Frisoni GB, Perani D, Bastianello S, Bernardi G, Porteri C, Boccardi M, Cappa SF, Trabucchi M, Padovani A.

Neurobiol Aging. 2017 Apr;52:119-131. doi: 10.1016/j.neurobiolaging.2016.02.033.

PMID:
28317643
45.

Evaluation of an optimized [18 F]fluoro-deoxy-glucose positron emission tomography voxel-wise method to early support differential diagnosis in atypical Parkinsonian disorders.

Caminiti SP, Alongi P, Majno L, Volontè MA, Cerami C, Gianolli L, Comi G, Perani D.

Eur J Neurol. 2017 May;24(5):687-e26. doi: 10.1111/ene.13269. Epub 2017 Feb 28.

PMID:
28244178
46.

The impact of bilingualism on brain reserve and metabolic connectivity in Alzheimer's dementia.

Perani D, Farsad M, Ballarini T, Lubian F, Malpetti M, Fracchetti A, Magnani G, March A, Abutalebi J.

Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1690-1695. doi: 10.1073/pnas.1610909114. Epub 2017 Jan 30.

47.

Validation of 18F-FDG-PET Single-Subject Optimized SPM Procedure with Different PET Scanners.

Presotto L, Ballarini T, Caminiti SP, Bettinardi V, Gianolli L, Perani D.

Neuroinformatics. 2017 Apr;15(2):151-163. doi: 10.1007/s12021-016-9322-9.

PMID:
28063108
48.

The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.

Cerami C, Dodich A, Greco L, Iannaccone S, Magnani G, Marcone A, Pelagallo E, Santangelo R, Cappa SF, Perani D.

J Alzheimers Dis. 2017;55(1):183-197.

49.

The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design.

Bonanni L, Cagnin A, Agosta F, Babiloni C, Borroni B, Bozzali M, Bruni AC, Filippi M, Galimberti D, Monastero R, Muscio C, Parnetti L, Perani D, Serra L, Silani V, Tiraboschi P, Padovani A; DLB-SINdem study group.

Neurol Sci. 2017 Jan;38(1):83-91. doi: 10.1007/s10072-016-2713-8. Epub 2016 Sep 13.

PMID:
27624723
50.

Neuropsychological and FDG-PET profiles in VGKC autoimmune limbic encephalitis.

Dodich A, Cerami C, Iannaccone S, Marcone A, Alongi P, Crespi C, Canessa N, Andreetta F, Falini A, Cappa SF, Perani D.

Brain Cogn. 2016 Oct;108:81-7. doi: 10.1016/j.bandc.2016.07.010.

PMID:
27566001

Supplemental Content

Loading ...
Support Center